M. Brusse-Keizer (Enschede, Netherlands), P. Burgel (Sorbonne Paris Cité, France)
Comparative analysis of rhythm disturbances in patients with chronic obstructive pulmonary disease (COPD). K. Klester (Barnaul, Russian Federation), E. Klester (Kazan, Russian Federation), A. Balitskaya (Barnaul, Russian Federation), A. Berdyugina (Barnaul, Russian Federation), V. Elykomov (Barnaul, Russian Federation), A. Zateev (Barnaul, Russian Federation)
|   |
COPD in patients evaluated for stable myocardial ischemia – observational study A. Jonsson (Malmö, Sweden), A. Fedorowski (Malmö, Sweden), G. Engstrom (Malmö, Sweden), P. Wollmer (Malmö, Sweden), V. Hamrefors (Malmö, Sweden)
|     |
Remodeling of common carotid and common femoral arteries in COPD patients without previously diagnosed cardiovascular diseases (CVD). V. Gaynitdinova (Moscow, Russian Federation), S. Avdeev (Moscow, Russian Federation), N. Tsareva (Moscow, Russian Federation), Z. Merzhoeva (Moscow, Russian Federation)
|    |
The role of interleukin 6 on incident atrial fibrillation in COPD patients M. Grymonprez (Ghent, Belgium), V. Vakaet (Ghent, Belgium), M. Kavousi (Rotterdam, Netherlands), B. Stricker (Rotterdam, Netherlands), M. Ikram (Rotterdam, Netherlands), J. Heeringa (Rotterdam, Netherlands), O. Franco (Rotterdam, Netherlands), G. Brusselle (Ghent, Belgium), L. Lahousse (Ghent, Belgium)
|     |
Mechanisms of Cardiac arrhythmias in patients with chronic obstructive disease (COPD) J. Ben Amar (Tunis, Tunisia), A. Saidane (Tunis, Tunisia), H. Zaibi (Tunis, Tunisia), M. Ben Halima (Tunis, Tunisia), S. Ouali (Tunis, Tunisia), M. Mourali (Tunis, Tunisia), B. Dhahri (Tunis, Tunisia), H. Aouina (Tunis, Tunisia)
|  |
Association of phase angle and hypoxemia in ambulatory patients with chronic obstructive pulmonary disease and heart failure. C. Olivo Villalobos (Mexico, Mexico), A. Orea-Tejeda (Mexico, Mexico), D. González-Islas (Mexico, Mexico), C. Chávez-Mendéz (Mexico, Mexico), G. Dávila-Said (Mexico, Mexico), R. Sánchez-Santillán (Mexico, Mexico), V. Peláez-Hernandéz (Mexico, Mexico), C. Espinosa-De Los Monteros (Mexico, Mexico), M. Rivera-Rodriguéz (Mexico, Mexico), L. Castillo-Aguilar (Mexico, Mexico), L. Hernández-Urquieta (Mexico, Mexico), K. Balderas-Muñoz (Mexico, Mexico)
|   |
Chronic obstructive pulmonary disease and cardiac remodeling: gender aspect. K. Klester (Barnaul, Russian Federation), E. Klester (Kazan, Russian Federation), A. Balitskaya (Barnaul, Russian Federation), A. Berdyugina (Barnaul, Russian Federation), V. Elykomov (Barnaul, Russian Federation), A. Zateev (Barnaul, Russian Federation)
|    |
Prevalence of comorbidities in established and newly treated patients with COPD according to GOLD 2017 in a UK primary care population D. Halpin (Exeter, United Kingdom), H. De Jong (Singapore, Singapore), V. Carter (Singapore, Singapore), D. Skinner (Singapore, Singapore), D. Price (Singapore, Singapore)
|     |
Microvascular coronary perfusion and hyperinflation in COPD – data from the LEAD (Lung, hEart, sociAl, boDy) study M. Urban (Vienna, Austria), M. Breyer (Vienna, Austria), R. Breyer-Kohansal (Vienna, Austria), A. Ofenheimer (Vienna, Austria), S. Hartl (Vienna, Austria), O. Burghuber (Vienna, Austria)
|     |
Impact of chronic obstructive pulmonary disease in hospitalized patients who undergo transcatheter aortic valve implantation A. Oliva Ramos (Madrid, Spain), J. De Miguel Díez (Madrid, Spain), E. Rodríguez Jimeno (Madrid, Spain), A. Cerezo Lajas (Madrid, Spain), L. Ramirez García (Madrid, Spain), L. Puente Maestu (Madrid, Spain), A. López De Andrés (Madrid, Spain), V. Hernández Barrera (Madrid, Spain), R. Jiménez García (Madrid, Spain)
|     |
COPD in symptomatic aortic stenosis: the importance of correct assessment for defining prognosis M. Rigolli (Oxford, United Kingdom), A. Rossi (Verona, Italy), P. Temporelli (Veruno, Italy), G. Benfari (Verona, Italy), G. Cioffi (Trento, Italy), N. Gaibazzi (Parma, Italy), S. Nistri (Altavilla Vicentina, Italy), F. Guidetti (Brescia, Italy), L. Tavazzi (Cotignola, Italy), S. Myerson (Oxford, United Kingdom), M. Bafadhel (Oxford, United Kingdom), P. Faggiano (Brescia, Italy)
|    |
Metabolic Syndrome negatively affects pulmonary function in COPD patients V. Liotino (Bari, Italy), M. Vulpi (Bari, Italy), A. Castrovilli (Bari, Italy), C. Tortorella (Bari, Italy), G. Piazzolla (Bari, Italy), M. Candigliota (Bari, Italy), O. Resta (Bari, Italy)
|    |
Osteoporosis onset in patients prescribed ICS for COPD: matched cohort study D. Price (Singapore, Singapore), J. Voorham (Singapore, Singapore), G. Brusselle (Ghent, Belgium), A. Clemens (Basel, Switzerland), R. Fogel (East Hanover, United States of America), H. Park (Seoul, Republic of Korea), J. Stephens (Wales, United Kingdom), N. Roche (Paris, France)
|     |
Visceral adiposity index in patients with chronic obstructive pulmonary disease S. Keskek (Adana, Turkey), O. Altinoz (Antakya, Turkey)
|   |
Non-traumatic vertebral fractures among COPD patients M. Koslow (Kfar Saba, Israel), G. Epstein-Shochet (Kfar Saba, Israel), L. Israeli-Shani (Kfar Saba, Israel), O. Wand (Kfar Saba, Israel), D. Shitrit (Kfar Saba, Israel)
|    |
Testosterone levels and their association with COPD severity: A cross sectional study. H. Castro (Buenos aires, Argentina), J. Maritano Furcada (Buenos aires, Argentina), P. Knoblovits (Buenos aires, Argentina), S. Suarez (Buenos aires, Argentina), P. Costanzo (Buenos aires, Argentina)
|    |
Lung cancer screening in COPD patients. M. Pascarella (Basel, Switzerland), D. Schumann (Basel, Switzerland), A. Stalder-Siebeneichler (Basel, Switzerland), E. Papakonstantinou (Basel, Switzerland), C. Giroy (Basel, Switzerland), N. Oertli (Basel, Switzerland), M. Tamm (Basel, Switzerland), D. Stolz (Basel, Switzerland)
|    |
Lung Cancer Screening Programs: a missed “window” to diagnose Obstructive Lung Disease. The NLST-ACRIN experience. J. De Torres Tajes (Pamplona, Spain), J. Wisnivesky (New York, United States of America), D. Wilson (Pittsburgh , United States of America), C. Casanova (Tenerife, Spain), J. Marin (Zaragoza, Spain), V. Pinto Plata (Springfield, United States of America), M. Divo (Boston, United States of America), F. Polverino (Boston, United States of America), C. Cabrera (Las Palmas, Spain), J. Zulueta (Pamplona, Spain), B. Celli (Boston, United States of America), G. Bastarrika (Pamplona, Spain)
|     |